What is GLP-1 Used For? Exploring Its Role in Weight Loss and Diabetes Management

Last reviewed: June 10, 2026

Last updated: June 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have emerged as powerful tools in modern medicine, with clinical studies showing average weight loss of 15-22% over 68 weeks in patients using semaglutide. Originally developed to treat type 2 diabetes, these medications now help millions manage both blood sugar and body weight through a single mechanism. Understanding how GLP-1 works can help you decide if this therapy aligns with your health goals.

How GLP-1 Medications Work in Your Body

GLP-1 stands for glucagon-like peptide-1, a hormone your intestines naturally release when you eat. This hormone signals your brain that you're full, slows stomach emptying, and helps your pancreas release insulin only when blood sugar rises. GLP-1 receptor agonist medications mimic this natural process, making your body behave as though it has more of this satiety hormone circulating.

When you take a GLP-1 medication like semaglutide, it activates GLP-1 receptors throughout your digestive system and brain. This triple action—reduced hunger signals, slower digestion, and improved insulin response—creates conditions where eating less feels natural rather than restrictive. The medication doesn't force weight loss; it resets your appetite set point, allowing sustainable changes in eating patterns.

GLP-1 for Type 2 Diabetes Management

Type 2 diabetes develops when cells stop responding properly to insulin or when the pancreas cannot produce enough. GLP-1 medications address both problems by improving insulin secretion in response to meals and increasing insulin sensitivity in muscle and fat cells. Clinical trials show that GLP-1 therapy reduces HbA1c levels (a three-month blood sugar average) by 1-2%, often matching or exceeding results from other diabetes drug classes.

Beyond blood sugar control, GLP-1 medications offer cardiovascular protection in people with diabetes. Large outcome studies demonstrate that semaglutide and tirzepatide reduce heart attacks, strokes, and cardiovascular death by 20-25% in high-risk populations. This dual benefit—improved glucose control plus heart protection—makes GLP-1 therapy a preferred first-line option for many diabetes specialists.

GLP-1 for Weight Loss Without Diabetes

GLP-1 medications have proven effective for weight loss in people without type 2 diabetes, a use approved by the FDA in 2021. People without diabetes who take semaglutide typically lose 10-15% of body weight over one year, with some achieving 20% or greater weight loss when combined with lifestyle modifications. This represents a meaningful shift in obesity treatment, offering a medical option that works alongside diet and exercise rather than replacing them.

Weight loss from GLP-1 therapy tends to be gradual and sustained because the medication addresses the hormonal and neurological drivers of appetite. Rather than relying on willpower alone, patients experience genuine reductions in hunger and food cravings, making calorie restriction feel more manageable. PlexusDx offers compounded semaglutide injection starting at $149 per month, making this therapy accessible without insurance barriers.

Genetic Factors That Influence Your GLP-1 Response

Not everyone responds to GLP-1 therapy at the same rate or intensity, partly because of genetic variations in the GLP-1 receptor and related appetite-control pathways. The PlexusDx Precision Peptide Genetic Test identifies your genetic predispositions across 14 metabolic pathways and 49 peptides, including key variants like GLP1R rs6923761 and GIPR rs1800437 that influence how effectively your body responds to GLP-1 medications. This $99 genetic test, available after your first month of treatment, helps predict your personalized response potential and guides dosing strategy.

Genetic insights also reveal whether your weight regulation challenges stem primarily from appetite control, metabolic rate, fat storage, or other factors. For example, individuals with certain FTO gene variants may experience stronger appetite-suppressing effects from GLP-1, while those with specific MC4R variations might benefit from dual-compound therapy like GLP-Squared. Precision Peptide Genetic Testing empowers you and your clinician to select the most effective medication formulation for your unique biology.

Choosing Between Semaglutide, Tirzepatide, and Combination Therapy

PlexusDx offers several GLP-1 formulations to match different needs and preferences. Compounded semaglutide injection starts at $149 per month and delivers pure GLP-1 activity, making it ideal for those prioritizing simplicity and established efficacy. Compounded tirzepatide injection starts at $249 per month and activates both GLP-1 and GIP receptors, producing slightly stronger weight loss effects (up to 22% in clinical trials) and may benefit patients with stronger genetic predispositions to GIP-pathway response.

For patients seeking maximum peptide activity, GLP-Squared injection combines semaglutide and tirzepatide in a single compound starting at $249 per month, offering dual-receptor activation without the complexity of managing two separate injections. Oral formulations are available for those who prefer tablets over injections—oral semaglutide at $249/month and oral tirzepatide at $279/month deliver the same active compounds through your digestive system. Your dose may need to go up as your body adjusts, but your price won't—PlexusDx maintains flat pricing across all three commitment tiers.

Safety, Side Effects, and What to Expect

GLP-1 medications are well-tolerated overall, though mild gastrointestinal side effects occur in the first weeks of therapy. Common experiences include nausea, constipation, or reduced appetite for favorite foods—ironically, the appetite suppression is the therapeutic effect, not a side effect. These sensations typically peak during the dose-escalation phase and diminish within 4-8 weeks as your body adapts. Serious side effects are rare in people without personal or family history of certain thyroid cancers or pancreatic conditions.

Your PlexusDx clinician will review your complete medical history before prescribing GLP-1 therapy, identifying any contraindications or special considerations. All medications come from licensed 503A compounding pharmacies—not 503B facilities—ensuring quality oversight and regulatory compliance. PlexusDx serves all 50 states, requires no insurance, and accepts HSA and FSA funds, removing financial barriers to accessing this proven therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I use GLP-1 medication if I don't have diabetes?

Yes. GLP-1 medications are FDA-approved for chronic weight management in people without diabetes who have a BMI of 30 or higher, or BMI of 27+ with weight-related conditions. PlexusDx offers compounded semaglutide injection starting at $149/month for both diabetes and weight loss applications.

How quickly will I see weight loss results with GLP-1?

Most patients begin noticing reduced hunger within the first week and gradual weight loss within 2-4 weeks. Meaningful weight loss (5-10% of body weight) typically emerges by 3 months, with continued progress over 12+ months as your dose reaches therapeutic levels. Results vary based on genetics, lifestyle, and individual metabolism.

Is compounded GLP-1 from PlexusDx as effective as brand-name medications?

PlexusDx medications contain the same active pharmaceutical ingredients as brand-name products and are manufactured by licensed 503A compounding pharmacies under strict quality standards. The difference is pricing—starting at $149/month for semaglutide instead of $900+—and improved accessibility without insurance requirements.

What happens to my weight if I stop taking GLP-1 medication?

Weight regain can occur after stopping GLP-1 therapy because your appetite-regulation hormones gradually return to baseline. Many patients maintain 50-70% of their weight loss long-term by incorporating the dietary and exercise habits they developed while on medication. Some choose to continue therapy indefinitely as a chronic weight management strategy, similar to blood pressure medication.

Will the Precision Peptide Genetic Test tell me which GLP-1 medication will work best for me?

Yes. The PlexusDx Precision Peptide Genetic Test ($99, available after your first month) analyzes 14 pathways and 49 peptides including GLP1R rs6923761 and GIPR rs1800437 variants, helping predict whether you'll respond better to semaglutide, tirzepatide, or dual-compound therapy. This personalized roadmap optimizes your medication selection and expected weight loss outcomes.

Related Reading

• Glp 1 For Weight Loss 2
• Glp 1 Weight Loss Before And After
• Glp 1 Dosage For Weight Loss
• Glp 1 Receptor Agonist For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.